7 Oct 2026Sudarshan Pharma Industries Ltd announces termination of proposal to acquire 9.50% equity in Med Therapy Biotechnology Inc., USARestructuring
28 Sept 2026Sudarshan Pharma Industries Ltd completes sale of 51% stake in Ishwari Healthcare Private Limited for ₹1.40 CroresRestructuring
22 Sept 2026Sudarshan Pharma Industries Ltd scrutinizer's report on voting results for 18th AGM held on 22 Sep 2026Record Date
22 Sept 2026Sudarshan Pharma Industries Ltd voting results of the 18th Annual General Meeting held on 22 Sep 2026Record Date
22 Sept 2026Sudarshan Pharma Industries Ltd outcome of 18th AGM held on 22 Sep 2026 via VC/OAVMRecord Date
15 Sept 2026Sudarshan Pharma Industries Ltd update on pending acquisition of 9.50% stake in Med Therapy Biotechnology Inc., USA under due diligenceRestructuring
5 Sept 2026Sudarshan Pharma Industries Ltd board approves acquisition of 9.50% stake in MedTherapy Biotechnology Inc. on 5 Sep 2026Restructuring
29 Aug 2026Sudarshan Pharma Industries Ltd AGM scheduled on 22 Sep 2026Record Date
19 Aug 2026Sudarshan Pharma Industries Ltd approves allotment of 48,11,730 equity shares upon conversion of FCCBs worth USD 15,00,000 on 19 Aug 2026Capital Raise
30 May 2026Sudarshan Pharma Industries Limited Annual Secretarial Compliance Report for FY26 under Regulation 24A scheduled on 30 May 2026Audit Reports
25 May 2026Sudarshan Pharma Industries Limited postal ballot notice for special resolutions through remote e-voting scheduled from May 26, 2026 to June 24, 2026Record Date
1 May 2026Sudarshan Pharma Industries Limited appointment of Directors and Chief Financial Officer w.e.f. 1st May, 2026 under Regulation 30 scheduled on 30 April 2026Record Date
